Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

1 competing product in clinical development for Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma.

Pipeline by Phase

Phase 11

All Products (1)

ProductCompanyStageStatusHype
zolbetuximabAstellas PharmaPhase 1Completed
29